150 related articles for article (PubMed ID: 15914292)
1. [Salmonella of Indian origin: pseudo-susceptibility to fluoroquinolones].
Denes E; Gondran G; Bezanahary H; Genet C; Rogez JP; Weinbreck P; Martin C
Med Mal Infect; 2005 Apr; 35(4):223-4. PubMed ID: 15914292
[TBL] [Abstract][Full Text] [Related]
2. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
3. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.
Kasper MR; Sokhal B; Blair PJ; Wierzba TF; Putnam SD
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):207-9. PubMed ID: 19800753
[TBL] [Abstract][Full Text] [Related]
4. [A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Gaborieau V; Weill FX; Marchou B
Med Mal Infect; 2010 Dec; 40(12):691-5. PubMed ID: 20724089
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
Kadhiravan T; Wig N; Kapil A; Kabra SK; Renuka K; Misra A
BMC Infect Dis; 2005 May; 5():37. PubMed ID: 15904505
[TBL] [Abstract][Full Text] [Related]
6. Typhoid fever: narrowing therapeutic options in India.
Capoor MR; Nair D; Hasan AS; Aggarwal P; Gupta B
Southeast Asian J Trop Med Public Health; 2006 Nov; 37(6):1170-4. PubMed ID: 17333772
[TBL] [Abstract][Full Text] [Related]
7. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
8. Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh.
Asna SM; Haq JA; Rahman MM
Jpn J Infect Dis; 2003 Feb; 56(1):32-3. PubMed ID: 12711825
[No Abstract] [Full Text] [Related]
9. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
[TBL] [Abstract][Full Text] [Related]
10. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
Crump JA; Barrett TJ; Nelson JT; Angulo FJ
Clin Infect Dis; 2003 Jul; 37(1):75-81. PubMed ID: 12830411
[TBL] [Abstract][Full Text] [Related]
11. [Salmonella typhi--time to change empiric treatment].
Gade C; Engberg J; Weis N
Ugeskr Laeger; 2008 Sep; 170(40):3133-4. PubMed ID: 18823602
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic difficulties in febrile travellers returning from the tropics. Two cases of typhoid fever imported from India].
Kacprzak E; Stefaniak J; Skoryna-Karcz B; Wojtacha A; Bolewska B; Juszczyk J
Pol Merkur Lekarski; 2002 Dec; 13(78):509-15. PubMed ID: 12666454
[TBL] [Abstract][Full Text] [Related]
13. Nalidixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella typhi isolated from blood.
Zafar A; Ibrahim NG; Ahsan T; Abbas Z; Zaidi A; Hasan R
J Coll Physicians Surg Pak; 2005 Jul; 15(7):413-7. PubMed ID: 16197870
[TBL] [Abstract][Full Text] [Related]
14. Typhoid fever due to multiresistant Salmonella enterica serovar typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance.
Panhotra BR; Saxena AK; Al-Ghamdi AM
Saudi Med J; 2004 Oct; 25(10):1509-11. PubMed ID: 15494840
[No Abstract] [Full Text] [Related]
15. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
16. Nalidixic acid-resistant Salmonella enterica serotype typhi infection presenting with sub-intestinal obstruction and mesenteric adenitis.
Al-Khuwaitir TS; Al-Zuhair AA; Al-Ghamdi AG; Khan A
Saudi Med J; 2008 Jan; 29(1):129-32. PubMed ID: 18176688
[TBL] [Abstract][Full Text] [Related]
17. Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi.
Rupali P; Abraham OC; Jesudason MV; John TJ; Zachariah A; Sivaram S; Mathai D
Diagn Microbiol Infect Dis; 2004 May; 49(1):1-3. PubMed ID: 15135492
[TBL] [Abstract][Full Text] [Related]
18. Low-level quinolone-resistance in multi-drug resistant typhoid.
Mirza SH; Khan MA
J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
[TBL] [Abstract][Full Text] [Related]
19. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
[TBL] [Abstract][Full Text] [Related]
20. Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India.
Dutta S; Sur D; Manna B; Sen B; Bhattacharya M; Bhattacharya SK; Wain J; Nair S; Clemens JD; Ochiai RL
Int J Antimicrob Agents; 2008 Apr; 31(4):387-9. PubMed ID: 18280709
[No Abstract] [Full Text] [Related]
[Next] [New Search]
